Usefulness of maternal anti-HPA-1a antibody quantitation in predicting severity of foetomaternal alloimmune thrombocytopenia

Transfusion Medicine

Volumn 23, Issue 2, 2013, Pages 114-120

  Sainio, S ^a   Javela, K ^a   Tuimala, J ^a   Koskinen, S ^a  

^a FINNISH RED CROSS BLOOD SERVICE   (Finland)

Author keywords

Anti HPA 1a; FMAIT; MAIPA

Indexed keywords

HPA 1A ANTIBODY; MATERNAL ANTIBODY; UNCLASSIFIED DRUG;

ARTICLE; ASPHYXIA; BRAIN HEMORRHAGE; DISEASE SEVERITY; FETUS DEATH; HUMAN; NEONATAL ALLOIMMUNE THROMBOCYTOPENIA; PREDICTIVE VALUE; PREGNANCY OUTCOME; PRIMIGRAVIDA; SECOND TRIMESTER PREGNANCY; SENSITIVITY AND SPECIFICITY; SKIN BLEEDING; SUBDURAL HEMATOMA; THROMBOCYTE COUNT;

ADULT; ANTIGENS, HUMAN PLATELET; AUTOANTIBODIES; FEMALE; FETOMATERNAL TRANSFUSION; HUMANS; INFANT, NEWBORN; MALE; PLATELET COUNT; PREDICTIVE VALUE OF TESTS; PREGNANCY; RETROSPECTIVE STUDIES; THROMBOCYTOPENIA, NEONATAL ALLOIMMUNE;

EID: 84875619080     PISSN: 09587578     EISSN: 13653148     Source Type: Journal    
DOI: 10.1111/tme.12018     Document Type: Article

References (28)

1. Allen, D., Rigsby, P., Bessos, H., Berry, J., Wilson, D. & Skogen, B. (2005) Collaborative study to establish the first WHO international standard for quantification of anti-HPA-1a. Vox Sanguinis, 89, 100-104.
2. Bertrand, G., Martageix, C., Jallu, V., Vitry, F. & Kaplan, C. (2005) Predictive value of sequential maternal anti-HPA-1a antibody concentrations for the severity of fetal alloimmune thrombocytopenia. Journal of Thrombosis and Haemostasis, 4, 628-637.
3. Bertrand, G., Drame, M., Martageix, C. & Kaplan, C. (2011) Prediction of the fetal status in noninvasive management of alloimmune thrombocytopenia. Blood, 117, 3209-3213.
4. Bertrand, G., Bakchoul, T., Javela, K., Kjaer Killie, M., Kaplan, C. & SSC of the ISTH (2012) Interlaboratory workshop on anti-HPA-1a alloantibody quantification with the mAb-specific immobilization of platelet antigen technique. Journal of Thrombosis and Haemostasis, 10, 1172-1174.
5. Bessos, H., Turnen, M. & Urbaniak, S. (2005) Is there a relationship between anti-HPA-1a concentration and severity of neonatal alloimmune thrombocytopenia? Immunohematology, 21, 102-108.
6. Bessos, H., Killie, M.K., Matviyenko, M., Husebekk, A. & Urbaniak, S.J. (2008) Direct comparison between two quantitative assays in the measurement of maternal anti-HPA-1a antibody in neonatal alloimmune thrombocytopenia. Transfusion and Apheresis Science, 39, 221-227.
7. Bessos, H., Killie, M.K., Seghatchian, J., Skogen, B. & Urbaniak, S.J. (2009) The relationship of anti-HPA-1a amount to severity of neonatal alloimmune thrombocytopenia - Where does it stand? Transfusion and Apheresis Science, 40, 75-78.
8. von dem Borne, A.E., Verheugt, F.W., Oosterhof, F., von Riesz, E., de la Riviere, A.B. & Engelfriet, C.P. (1978) A simple immunofluorescence test for the detection of platelet antibodies. British Journal of Haematology, 39, 195-207.
9. Burrows, R.F. & Kelton, J.G. (1993) Fetal thrombocytopenia and its relation to maternal thrombocytopenia. The New England Journal of Medicine, 329, 1463-1466.
10. Bussel, J. (2009) Diagnosis and management of the fetus and neonate with alloimmune thrombocytopenia. Journal of Thrombosis and Haemostasis, 7, 253-257.
11. Bussel, J.B., Zacharoulis, S., Kramer, K., McFarland, J.G., Pauliny, J. & Kaplan, C. (2005) Clinical and diagnostic comparison of neonatal alloimmune thrombocytopenia to non-immune cases of thrombocytopenia. Pediatric Blood & Cancer, 45, 176-183.
12. Bussel, J.B., Berkowitz, R.L., Hung, C., Kolb, E.A., Wissert, M., Primiani, A., Tsaur, F.W. & MacFarland, J.G. (2010) Intracranial haemorrhage in alloimmune thrombocytopenia: stratified management to prevent recurrence in the subsequent affected fetus. American Journal of Obstetrics and Gynecology, 203, 135e1-4.
13. Dawkins, B. (1995) Monitoring anti-HPA-1a platelet antibody levels during pregnancy using the MAIPA test. Vox Sanguinis, 68, 27-34.
14. Dreyfus, M., Kaplan, C., Verdy, E., Schlegel, N., Durand-Zaleski, I., Tchernia, G. & the immune Thrombocytopenia Working Group (1997) Frequency of immune thrombocytopenia in newborns: a prospective study. Blood, 89, 4420-4406.
15. Ghevaert, C., Campbell, K., Stafford, P., Metcalfe, P., Casbard, A., Smith, G.A., Allen, D., Ranasighe, E., Williamson, L.M. & Ouwehand, W.H. (2007) HPA-1a antbody potency and bioactivity do not predict severity of fetomaternal alloimmune thrombocytopenia. Transfusion, 47, 1296-1305.
16. Kamphuis, M.M. & Oepkes, D. (2011) Fetal and neonatal alloimmune thrombocytopenia: prenatal interventions. Prenatal Diagnosis, 31, 712-719.
17. Kiefel, V., Santoso, S., Weisheit, M. & Mueller-Eckhart, C. (1987) Monoclonal antibody-specific immobilization of platelet antigens (MAIPA): a new tool for the identification of platelet reactive antibodies. Blood, 70, 1722-1726.
18. Killie, M.K., Husebekk, A., Kaplan, C., Taaning, E. & Bjorn, S. (2007) Maternal human platelet antigen-1a antibody level correlates with the platelet count in the newborns: a retrospective study. Transfusion, 47, 55-58.
19. Killie, M.K., Husebekk, A., Kjeldsen-Kragh, J. & Bjorn, S. (2008) A prospective study of maternal anti-HPA 1a antibody level as a potential predictor of alloimmune thrombocytopenia in the newborn. Heamatologica, 93, 870-877.
20. Kroll, H., Penke, G. & Santoso, S. (2005) Functional heterogeneity of alloantibodies against the human platelet antigen (HPA)-1a. Thrombosis and Haemostasis, 94, 1224-1229.
21. Mechoulan, A., Kaplan, C., Muller, J.Y., Branger, B., Philippe, H.J., Oury, J., Ville, Y. & Winer, N. (2011) Fetal alloimmune thrombocytopenia: is less invasive antenatal management safe? The Journal of Maternal-Fetal & Neonatal Medicine, 24, 564-567.
22. Mueller-Eckhardt, C., Kiefel, V., Grubert, A., Kroll, H., Weisheit, M., Schmidt, S., Mueller-Eckhardt, G. & Santoso, S. (1989) 384 cases of suspected neonatal alloimmune thrombocytopenia. Lancet, 1, 363-366.
23. Radder, C.M., Brand, A. & Kanhai, H.H.H. (2003) Will it ever be possible to balance the risk of intracranial hemorrhage in fetal or neonatal alloimmune thrombocytopenia against the risk of treatment strategies to prevent it? Vox Sanguinis, 84, 318-325.
24. Socher, I., Andrei-Selmer, C., Gregor, B., Kroll, H. & Santoso, S. (2009) Low-avidity HPA-1a alloantibodies in severe neonatal alloimmune thrombocytopenia are detectable with surface plasmon resonance technology. Transfusion, 49, 943-951.
25. Van den Akker, E., Oepkes, D., Lopriore, E., Brand, A. & Kanhai, H. (2007) Noninvasive antenatal management of fetal and neonatal alloimmune thrombocytopenia: safe and effective. BJOG: An International Journal of Obstetrics and Gynaecology, 114, 469-473.
26. Vinogard, C.A. & Bussel, J.B. (2010) Antenatal treatment of fetal alloimmune thrombocytopenia: a current perspective. Haematologica, 95, 1807-1811.
27. a) as determinant by antenatal screening. Blood, 92, 2280-2287.
28. Wuhrer, M., Porcelijn, L., Kapur, R., Koeleman, C.A.M., Deelder, A.M., de, Haas, M. & Vidarsson, G. (2009) Regulated glycosylation patterns of IgG during alloimmune responses against human platelet antigens. Journal of Proteome Research, 8, 450-456.